Atlas Trials

Digoxin for the Reinduction of Radioiodine Uptake in Metastatic or Locally Advanced Non-medullary Thyroid Carcinoma

Clinical trial NCT05507775 · COMPLETED

Trial details

NCT number
NCT05507775
Sponsor
Radboud University Medical Center
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Non-Medullary Thyroid Carcinoma
Start date
2022-12-06
Primary completion
2023-06-21
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.